Table 2 Differential effect of selected metabolites on the growth of Jurkat cells and normal lymphoblasts
From: Identification of metabolites with anticancer properties by computational metabolomics
| Â | Â | Jurkat | Lymphoblasts | ||||
|---|---|---|---|---|---|---|---|
Metabolite | c [μM]1 | Growth [%] | SEM [%]2 | p-value | Growth [%] | SEM [%]2 | p-value |
Menaquinone | 100 | 18.2 | 0.36 | 4.5 × 10-7 | 89.7 | 8.5 | 0.38 |
|  | 50 | 40.3 | 1.15 | 2.0 × 10-7 | 109.9 | 5.8 | 0.23 |
Dehydroepiandrosterone | 100 | 23.8 | 0.18 | 2.1 × 10-6 | 94.9 | 0.6 | 0.15 |
|  | 50 | 83.2 | 0.23 | 2.0 × 10-3 | 130.8 | 6.9 | 0.020 |
Se-Seleno-L-methionine | 100 | 41.0 | 0.67 | 1.0 × 10-7 | 79.3 | 5.8 | 0.028 |
|  | 50 | 53.2 | 0.85 | 2.0 × 10-3 | 84.2 | 1.4 | 2.7 × 10-4 |
5,6-dimethylbenzimidazole | 100 | 80.4 | 3.56 | 6.2 × 10-3 | 82.9 | 4.4 | 0.023 |
| Â | 50 | 87.8 | 1.41 | 0.021 | 97.4 | 1.9 | 0.037 |